The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats

被引:654
作者
Fresco, DM
Coles, ME
Heimberg, RG
Liebowitz, MR
Hami, S
Stein, MB
Goetz, D
机构
[1] Temple Univ, Adult Anxiety Clin, Philadelphia, PA 19122 USA
[2] Columbia Univ, New York State Psychiat Inst, Anxiety Disorders Clin, New York, NY USA
[3] Columbia Univ, Dept Psychiat, New York, NY USA
[4] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
关键词
D O I
10.1017/S0033291701004056
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. The clinician-administered version of the Liebowitz Social Anxiety Scale (LSAS-CA) is a commonly used assessment device for the evaluation of social anxiety disorder and has been shown to have strong psychometric characteristics. Because of its apparently straightforward rating format and potential savings in time and effort, interest in the use of the LSAS as a self-report (LSAS-SR) measure has increased, and the LSAS-SR has been used in a number of studies. However, the psychometric properties of the LSAS-SR have not been well established. Methods. This study examined the psychometric properties of the LSAS-SR in comparison to the LSAS-CA in a sample of 99 individuals with a primary diagnosis of social anxiety disorder and 53 individuals with no current psychiatric disorder. Results. There was little difference between the two versions of the LSAS on any scale or subscale score. Both forms were internally consistent and the subscale intercorrelations for the two forms were essentially identical. Correlations of each LSAS-SR index with its LSAS-CA counterpart were all highly significant. Finally, the convergent and discriminant validity of the two forms of the LSAS was shown to be strong. Conclusion. Results of this study Suggest that the self-report version of the LSAS compares well to the clinician-administered version and may be validly employed in the assessment of social anxiety disorder.
引用
收藏
页码:1025 / 1035
页数:11
相关论文
共 40 条
[1]  
American Psychiatric Association, 1994, DIAGN STAT MAN MENT
[2]   Paroxetine in social phobia/social anxiety disorder -: Randomised, double-blind, placebo-controlled study [J].
Baldwin, D ;
Bobes, J ;
Stein, DJ ;
Scharwächter, I ;
Faure, M .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 175 :120-126
[3]   PSYCHOMETRIC PROPERTIES OF THE BECK DEPRESSION INVENTORY - 25 YEARS OF EVALUATION [J].
BECK, AT ;
STEER, RA ;
GARBIN, MG .
CLINICAL PSYCHOLOGY REVIEW, 1988, 8 (01) :77-100
[4]  
BECK AT, 1979, COGNITIVE THERAPY DE
[5]   MEASURES OF DEPRESSIVE DIMENSIONS - ARE THEY INTERCHANGEABLE [J].
BLANEY, PH ;
KUTCHER, GS .
JOURNAL OF PERSONALITY ASSESSMENT, 1991, 56 (03) :502-512
[6]   Validation of the social interaction anxiety scale and the social phobia scale across the anxiety disorders [J].
Brown, EJ ;
Turovsky, J ;
Heimberg, RG ;
Juster, HR ;
Brown, TA ;
Barlow, DH .
PSYCHOLOGICAL ASSESSMENT, 1997, 9 (01) :21-27
[7]  
BUMBERRY W, 1978, J CONSULT CLIN PSYCH, V46, P150, DOI 10.1037/0022-006X.46.1.150
[8]  
COLES ME, 2001, IN PRESS DEPRESSION
[9]   A comparison of social phobia outcome measures in cognitive-behavioral group therapy [J].
Cox, BJ ;
Ross, L ;
Swinson, RP ;
Direnfeld, DM .
BEHAVIOR MODIFICATION, 1998, 22 (03) :285-297
[10]  
Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297